Europe Syndromic Multiplex Diagnostic Market to 2032
Overview
The Europe Syndromic Multiplex Diagnostic Market is expected to reach a 2.20 USD Billion by 2032 and is projected to grow at a CAGR of 8.22% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.17
Forecast, 2032 (USD Billion)
2.20
CAGR, 2024 - 2032
8.22%
Report Coverage
Europe
Europe Syndromic Multiplex Diagnostic Market 2018-2032 USD Billion
Europe Syndromic Multiplex Diagnostic Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.17 USD Billion
- Projected Market Size (2032): 2.20 USD Billion
- CAGR (2025-2032): 8.22%
Key Findings of Europe Syndromic Multiplex Diagnostic Market
- The Europe Syndromic Multiplex Diagnostic Market was valued at 2.20 USD Billion in 2024.
- The Europe Syndromic Multiplex Diagnostic Market is likely to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 0.82 USD Billion
- The fastest growing segment Respiratory Infections in Disease Segment grew Fastest with a CAGR of 9.40% during the forecast period from 2024 to 2032.
Europe Syndromic Multiplex Diagnostic Market Scope
Europe Syndromic Multiplex Diagnostic Market Segmentation & Scope
Product Type
- Software & Services
- Instruments
- Accessories & Consumables
End User
- Research Institutes
- Others
- Pharmaceutical & Biotechnology Companies
- Physician Offices
- Clinical Laboratories
- Hospitals
Disease
- Eye Infections
- Hepatitis
- Tropical Fever
- Immunosuppression
- Other Diseases
- Childhood Infections
- Meningitis
- Sexually Transmitted Infections
- Gastroenteritis
- Respiratory Infections
Infection Type
- Others
- Parasites
- Fungal
- Bacterial
- Viral
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Europe Syndromic Multiplex Diagnostic Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.17 USD Billion |
| Market Value in 2032 | 2.20 USD Billion |
| CAGR (2025-2032) | 8.22% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,End User,Disease,Infection Type,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 1.17 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 274.71 USD Million in 2024.
Segments and Scope
-
Europe Syndromic Multiplex Diagnostic Market to 2032, By Product Type
- Accessories & Consumables is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 732.85 USD Billion in the year 2024.
- Accessories & Consumables is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.52 % in forecast period 2025-2032.
-
Europe Syndromic Multiplex Diagnostic Market to 2032, By End User
- Hospitals is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 525.51 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.64 % in forecast period 2025-2032.
-
Europe Syndromic Multiplex Diagnostic Market to 2032, By Disease
- Respiratory Infections is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 392.84 USD Billion in the year 2024.
- Respiratory Infections is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 9.40 % in forecast period 2025-2032.
-
Europe Syndromic Multiplex Diagnostic Market to 2032, By Infection Type
- Viral is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 546.46 USD Billion in the year 2024.
- Viral is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.50 % in forecast period 2025-2032.
-
Europe Syndromic Multiplex Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a revenue of 823.15 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Syndromic Multiplex Diagnostic Market to 2032 with a Growth rate of 8.36 % in forecast period 2025-2032.
Europe Syndromic Multiplex Diagnostic Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| BIOMÉRIEUX | |||
| DiaSorin S.p.A | |||
| F. Hoffmann-La Roche Ltd. | |||
Europe Syndromic Multiplex Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Syndromic Multiplex Diagnostic Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,End User,Disease,Infection Type,Distribution Channel.
Europe Syndromic Multiplex Diagnostic Market was valued at USD 1.17(Revenue in USD Billion) in 2024.
Europe Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Europe Syndromic Multiplex Diagnostic Market, holding a largest market share of 0.82 USD Billion in 2024
Europe Syndromic Multiplex Diagnostic Market Scope
Europe Syndromic Multiplex Diagnostic Market Segmentation & Scope
Product Type
- Software & Services
- Instruments
- Accessories & Consumables
End User
- Research Institutes
- Others
- Pharmaceutical & Biotechnology Companies
- Physician Offices
- Clinical Laboratories
- Hospitals
Disease
- Eye Infections
- Hepatitis
- Tropical Fever
- Immunosuppression
- Other Diseases
- Childhood Infections
- Meningitis
- Sexually Transmitted Infections
- Gastroenteritis
- Respiratory Infections
Infection Type
- Others
- Parasites
- Fungal
- Bacterial
- Viral
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Europe Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,End User,Disease,Infection Type,Distribution Channel.
Europe Syndromic Multiplex Diagnostic Market was valued at USD 1.17(Revenue in USD Billion) in 2024.
Europe Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Syndromic Multiplex Diagnostic Market for final year is USD 2.20 (USD Billion).
Europe Syndromic Multiplex Diagnostic Market Company Profiling
Frequently Asked Questions
The Europe Syndromic Multiplex Diagnostic Market is segmented based on Segmentation Product Type,End User,Disease,Infection Type,Distribution Channel.
Europe Syndromic Multiplex Diagnostic Market was valued at USD 1.17(Revenue in USD Billion) in 2024.
Europe Syndromic Multiplex Diagnostic Market is projected to grow at a CAGR of 8.22% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Syndromic Multiplex Diagnostic Market for final year is USD 2.20 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.